Can I experience weight gain after bilateral intra‑articular corticosteroid injections in my knees?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Weight Gain After Bilateral Intra-Articular Corticosteroid Knee Injections

Clinically significant weight gain is not an expected outcome after bilateral intra-articular corticosteroid injections in the knees. The systemic absorption from joint injections is minimal and transient, producing only temporary metabolic effects that do not typically result in weight gain.

Systemic Effects of Intra-Articular Corticosteroids

The available evidence demonstrates that intra-articular corticosteroid injections do produce measurable systemic effects, but these are time-limited and do not include weight gain as a documented outcome:

  • Serum cortisol suppression occurs within hours after injection, with a nadir typically at 24-48 hours, and recovery to baseline takes 1-4 weeks depending on the corticosteroid type and dose 1

  • Transient hyperglycemia can occur in patients with diabetes, with blood glucose levels peaking around 300 mg/dL over 2-3 days in patients with otherwise good glucose control 1, 2

  • Inflammatory marker reduction (C-reactive protein, ESR) begins within days and can persist for months, with immediate effects on inflammatory cytokines 1

Why Weight Gain Is Not Expected

The key distinction here is that intra-articular injections deliver corticosteroids locally to the joint space, not systemically like oral or intramuscular corticosteroids:

  • Systemic (oral or intramuscular) corticosteroids have no established role in osteoarthritis management and are not approved for this indication 3

  • The metabolic effects documented in the literature (glucose elevation, cortisol suppression) are acute and self-limited, resolving within days to weeks 1, 2

  • None of the major clinical guidelines or systematic reviews addressing intra-articular corticosteroid safety mention weight gain as an adverse effect 4, 5, 3, 5, 6, 7

Documented Adverse Effects to Monitor

The actual concerns with intra-articular corticosteroid injections are different from systemic steroid side effects:

  • Cartilage thickness loss has been observed on MRI, though the American College of Rheumatology notes this lacks clinical significance because it does not correlate with worsening pain, function, or radiographic deterioration 6, 7

  • Long-term risks with repeated injections include potential effects on bone health, joint structure, and meniscal thickness 3, 6

  • Transient hyperglycemia for 2-3 days in diabetic patients, but this is clinically minimal 2

  • Infection risk if injections are performed within 3 months before joint replacement surgery 3, 6

Clinical Bottom Line

If you experience weight gain after bilateral knee injections, look for alternative explanations rather than attributing it to the corticosteroid injections themselves. The pain relief from the injections (typically lasting 1-4 weeks) 3, 6 might allow increased activity or changes in eating patterns, but the injections themselves do not cause the fluid retention, increased appetite, or metabolic changes associated with systemic corticosteroid therapy 1.

Related Questions

What are the criteria and indications for knee intra‑articular steroid injections, and should plain radiographs and a course of physical therapy be tried first?
A patient who received an intra‑articular knee corticosteroid injection 6 weeks ago, can they receive another steroid injection today for overall inflammation?
Should I be concerned about a persistently elevated ferritin level of 454 ng/mL over the past year in a patient receiving periodic intra‑articular corticosteroid injections for a painful shoulder?
What patient instructions should be provided after a corticosteroid injection in the knee?
Is it contraindicated to perform a pulmonary function test (PFT) after an intra‑articular steroid injection?
How should I evaluate and manage a 12‑year‑old girl with heavy menstrual bleeding (menorrhagia)?
What local anaesthetic agents and adjuvant drugs are used for spinal anaesthesia, including typical doses and patient‑specific considerations?
After a surgical or medical abortion, what is the expected pattern and timeline for quantitative beta‑human chorionic gonadotropin (β‑hCG) decline, and how should it be monitored to identify incomplete evacuation or complications?
What is the step‑by‑step technique for performing spinal anaesthesia in an adult patient without contraindications undergoing surgeries below the umbilicus, obstetric procedures, or lower‑extremity operations?
Which medications are hepatotoxic and how should they be prescribed and monitored in patients with existing liver disease or risk factors for hepatic injury?
What is the incidence of retained common bile duct stones after routine elective laparoscopic cholecystectomy for symptomatic gallstones in adult patients (approximately 50 years old, both sexes)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.